Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Suppression of local type I interferon by gut microbiota–derived butyrate impairs antitumor effects of ionizing radiation
Kaiting Yang, Yuzhu Hou, Yuan Zhang, et al.
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 3
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
Melody Smith, Anqi Dai, Guido Ghilardi, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 713-723
Open Access | Times Cited: 190
Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy
Yang Li, Aitian Li, Ying Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 188
Role of the cGAS–STING pathway in systemic and organ-specific diseases
Sladjana Skopelja‐Gardner, Jie An, Keith B. Elkon
Nature Reviews Nephrology (2022) Vol. 18, Iss. 9, pp. 558-572
Open Access | Times Cited: 169
The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer
Gauri Mirji, Alison Worth, Sajad A. Bhat, et al.
Science Immunology (2022) Vol. 7, Iss. 75
Open Access | Times Cited: 161
Targeting the gut microbiota for cancer therapy
Miriam R. Fernandes, Poonam Aggarwal, Raquel Costa, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 12, pp. 703-722
Closed Access | Times Cited: 149
Gut Microbiota-Derived Short-Chain Fatty Acids: Impact on Cancer Treatment Response and Toxicities
Ghanyah Al-Qadami, Kate R. Secombe, Courtney B. Subramaniam, et al.
Microorganisms (2022) Vol. 10, Iss. 10, pp. 2048-2048
Open Access | Times Cited: 80
The role of gut microbiota in T cell immunity and immune mediated disorders
Ju A Shim, Jeong Ha Ryu, Yuna Jo, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 4, pp. 1178-1191
Open Access | Times Cited: 64
Lachnospiraceae -derived butyrate mediates protection of high fermentable fiber against placental inflammation in gestational diabetes mellitus
Shuangbo Huang, Jianzhao Chen, Zhijuan Cui, et al.
Science Advances (2023) Vol. 9, Iss. 44
Open Access | Times Cited: 42
Role of the microbiota in response to and recovery from cancer therapy
Stephen J. Blake, Yochai Wolf, Ben Boursi, et al.
Nature reviews. Immunology (2023) Vol. 24, Iss. 5, pp. 308-325
Closed Access | Times Cited: 41
Short‐chain fatty acids: bridges between diet, gut microbiota, and health
Ling‐Yun Wang, Lihong He, Lijun Xu, et al.
Journal of Gastroenterology and Hepatology (2024) Vol. 39, Iss. 9, pp. 1728-1736
Open Access | Times Cited: 19
Multi-stage mechanisms of tumor metastasis and therapeutic strategies
Zaoqu Liu, Jingqi Chen, Yuqing Ren, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Radiotherapy and immunotherapy: open questions and future strategies
Kelli B. Pointer, Sean P. Pitroda, Ralph R. Weichselbaum
Trends in cancer (2021) Vol. 8, Iss. 1, pp. 9-20
Closed Access | Times Cited: 101
The oligometastatic spectrum in the era of improved detection and modern systemic therapy
Rohan R. Katipally, Sean P. Pitroda, Aditya Juloori, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 9, pp. 585-599
Closed Access | Times Cited: 55
Microbial short-chain fatty acids: a strategy to tune adoptive T cell therapy
Priya Rangan, Anna Mondino
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 7, pp. e004147-e004147
Open Access | Times Cited: 52
Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapy
Mireia Uribe‐Herranz, Silvia Beghi, Marco Ruella, et al.
Molecular Therapy (2023) Vol. 31, Iss. 3, pp. 686-700
Open Access | Times Cited: 26
High-fat diet promotes colitis-associated tumorigenesis by altering gut microbial butyrate metabolism
Xinyu Shao, Luojie Liu, Yuqing Zhou, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 15, pp. 5004-5019
Open Access | Times Cited: 26
Baseline gut microbiota composition is associated with oral mucositis and tumour recurrence in patients with head and neck cancer: a pilot study
Ghanyah Al-Qadami, Joanne M. Bowen, Ysabella Van Sebille, et al.
Supportive Care in Cancer (2023) Vol. 31, Iss. 1
Open Access | Times Cited: 22
Host-Gut Microbiota Metabolic Interactions and Their Role in Precision Diagnosis and Treatment of Gastrointestinal Cancers
Chunhao Cao, Siran Yue, Aiping Lu, et al.
Pharmacological Research (2024) Vol. 207, pp. 107321-107321
Open Access | Times Cited: 12
Microbiome in radiotherapy: an emerging approach to enhance treatment efficacy and reduce tissue injury
Lina Lu, Fengxiao Li, Yuanyuan Gao, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 10
Faecalibacterium duncaniae as a novel next generation probiotic against influenza
Loïc Chollet, Séverine Heumel, Lucie Deruyter, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
STING in Cancer Immunoediting: Modeling Tumor-Immune Dynamics Throughout Cancer Development
Xiao Zhang, Yan Chen, Xi Liu, et al.
Cancer Letters (2025) Vol. 612, pp. 217410-217410
Open Access | Times Cited: 1
Short-Chain Fatty Acids: Promising Therapeutic Targets for Respiratory Syncytial Virus Infection
Liang Mao, Qiang Dong, Weiyi Wu, et al.
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Closed Access | Times Cited: 1
Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients
Jianzhou Chen, Antonin Lévy, Ai-Ling Tian, et al.
Cancer Cell (2025) Vol. 43, Iss. 3, pp. 361-379.e10
Open Access | Times Cited: 1
Gut-derived butyrate suppresses ocular surface inflammation
Laura Schaefer, Humberto Hernandez, Rosalind A. Coats, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 33
Effects of Gut Microbiota on Host Adaptive Immunity Under Immune Homeostasis and Tumor Pathology State
Yanan Li, Zixuan Ye, Jianguo Zhu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top